ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years
Yujie Zhou
Matched on ORCID iD 0000-0002-6740-9818; OpenAlex author ID A5031231828. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- Serum carnitine and cancer risk: a Mendelian randomization study identifying pancreatic cancer as a modifiable metabolic target. First author DOI 10.1007/s12672-025-03161-3↗
- Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort. Co-author DOI 10.1080/21645515.2022.2143154↗
- Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer. Co-author DOI 10.3389/fmolb.2020.569842↗
- Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data. Co-author DOI 10.1089/dna.2019.4862↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaoqing Zhou · 1 shared paper, 2025 · strength 0.33
- Xin Lv · 1 shared paper, 2025 · strength 0.33
- Changchang Lu · 1 shared paper, 2022 · strength 0.14
- Juan Du · 1 shared paper, 2022 · strength 0.14
- Xiaoling Gong · 1 shared paper, 2022 · strength 0.14
- Xin Qiu · 1 shared paper, 2022 · strength 0.14
- Qiao-Li Wang Wang · 1 shared paper, 2022 · strength 0.14
- Fan Tong · 1 shared paper, 2022 · strength 0.14
- Baorui Liu · 1 shared paper, 2022 · strength 0.14
- Xiaobo Li · 1 shared paper, 2020 · strength 0.11
- Xiaobo Li · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.